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Review
Agricultural workers are exposed to a variety 
of chemical, physical, and biological hazards 
in the process of cultivating and harvesting 
crops and/or raising livestock (Litchfield 
1999; Popendorf and Donham 1991; Shaver 
and Tong 1991; White and Cessna 1989). 
In addition to pesticides, occupational expo-
sure to solvents, metals, engine exhaust, weld-
ing fumes, and grain dusts are prevalent in 
agriculture (Coble et al. 2002; Shaver and 
Tong 1991). However, the potential health 
effects of agricultural pesticide exposures are 
of particular interest, as these chemicals are 
designed to have adverse biological effects on 
target organisms. To address this concern, the 
Agricultural Health Study (AHS) was initi-
ated in 1993 to explore the potential health 
effects of pesticide exposures in commer-
cial pesticide applicators, farmers, and their 
families in Iowa and North Carolina, USA. 
The AHS is a collaborative research project 
including the U.S. National Cancer Institute, 
the U.S. National Institute of Environmental 
Health Sciences, and the U.S. Environmental 
Protection Agency (EPA).
Details of the AHS design have been 
described previously (Alavanja et al. 1996). 
Briefly, participants were recruited between 
1993 and 1997 from pesticide applicator 
licensing facilities in Iowa and North Carolina, 
and an enrollment questionnaire was used to 
collect data on the duration and frequency 
of pesticide use. In the AHS, self-reported 
pesticide use serves as a surrogate measure of 
pesticide exposure, and a cumulative pesticide 
exposure index (termed intensity-weighted 
exposure-days) is used to weigh lifetime-days 
(LDs) of pesticide use based on mixing condi-
tions, application methods, and use of per-
sonal protective equipment (Dosemeci et al. 
2002). Applicators who completed the enroll-
ment questionnaire were asked to complete 
a take-home questionnaire that collected 
detailed information on factors including 
occupational exposures, pesticide use, lifestyle, 
medical history, and diet. Two additional 
take-home questionnaires were provided for 
private applicators: a spouse questionnaire 
and a female/family health questionnaire. 
Commercial applicators were asked to com-
plete a female health questionnaire if they were 
female, but spouses and children of commer-
cial applicators were not included in the AHS. 
A total of 52,395 private pesticide applicators 
(farmers or nursery workers), 32,347 spouses 
of private applicators, and 4,916 commer-
cial pesticide applicators were enrolled in the 
AHS. Applicators are primarily male (> 95%); 
spouses are predominantly female (99.3%) 
(Alavanja et al. 2005). Private applicators, 
commercial applicators, and spouses are all 
predominantly Caucasian (94.6–98.6%) 
(Alavanja et al. 2005). At enrollment, 65% 
of private applicators reported pesticide 
exposure for > 11 years relative to 32% and 
18% for commercial applicators and spouses 
of private applicators, respectively (Alavanja 
et al. 2005). Twelve percent of private appli-
cators, 2.5% of commercial applicators, and 
3.6% of spouses reported > 30 years of pesti-
cide use at enrollment (Alavanja et al. 2005). 
Information provided at enrollment (phase 1) 
was updated in phase 2 (1999–2003) and 
phase 3 (2003–2010) of the AHS.
Approximately 80% of eligible applica-
tors completed the enrollment questionnaire 
(Tarone et al. 1997). Forty percent of eligible 
applicators completed both the enrollment 
questionnaire and the take-home questionnaire 
(Tarone et al. 1997). Seventy-four percent 
of eligible spouses were enrolled in the AHS 
(Engel et al. 2005). Applicators who completed 
the take-home questionnaire tended to be 
older than nonrespondents but were otherwise 
similar to respondents with respect to pesticide 
use practices, medical history, and other char-
acteristics such as education, smoking, alcohol 
consumption, and diet (Tarone et al. 1997). 
The reliability of self-reported pesticide use 
did not vary substantially by age, education, or 
farm size, and respondents generally provided 
plausible information regarding the duration 
and year of first pesticide use (Blair et al. 2002; 
Hoppin et al. 2002b).
In this review we focused on epidemio-
logic studies of pesticide exposure and cancer 
incidence in the AHS cohort. Studies of phys-
ical injury (Sprince et al. 2002, 2003a, 2003b, 
2003c, 2007), mortality (Blair et al. 2005a, 
2005b; Lee et al. 2007a), respiratory disorders 
(Hoppin et al. 2002a, 2006a, 2006b, 2007a, 
2007b, 2008; Valcin et al. 2007), neurologic 
symptoms (Kamel et al. 2005, 2007a), reti-
nal degeneration (Kamel et al. 2000; Kirrane 
et al. 2005), diabetes (Montgomery et al. 
2008; Saldana et al. 2007), menstrual cycle 
characteristics (Farr et al. 2004, 2006), hear-
ing loss (Crawford et al. 2008), Parkinson’s 
disease (Kamel et al. 2007b), changes in 
serum androgen levels (Martin et al. 2002), 
arthritis (De Roos et al. 2005b), depression 
(Beseler et al. 2006, 2008), and immune 
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oB j e c t i v e: We reviewed epidemiologic evidence related to occupational pesticide exposures and 
cancer incidence in the Agricultural Health Study (AHS) cohort. 
da t a s o u r c e s: Studies were identified from the AHS publication list available at http://aghealth.
nci.nih.gov as well as through a Medline/PubMed database search in March 2009. We also exam-
ined citation lists. Findings related to lifetime-days and/or intensity-weighted lifetime-days of 
pesticide use are the primary focus of this review, because these measures allow for the evaluation of 
potential exposure–response relationships.
da t a synthesis: We reviewed 28 studies; most of the 32 pesticides examined were not strongly 
associated with cancer incidence in pesticide applicators. Increased rate ratios (or odds ratios) and 
positive exposure–response patterns were reported for 12 pesticides currently registered in Canada 
and/or the United States (alachlor, aldicarb, carbaryl, chlorpyrifos, diazinon, dicamba, S-ethyl-
N,N-dipropylthiocarbamate, imazethapyr, metolachlor, pendimethalin, permethrin, trifluralin). 
However, estimates of association for specific cancers were often imprecise because of small num-
bers of exposed cases, and clear monotonic exposure–response patterns were not always apparent. 
Exposure misclassification is also a concern in the AHS and may limit the analysis of exposure–
response patterns. Epidemiologic evidence outside the AHS remains limited with respect to most of 
the observed associations, but animal toxicity data support the biological plausibility of relationships 
observed for alachlor, carbaryl, metolachlor, pendimethalin, permethrin, and trifluralin.
co n c l u s i o n s: Continued follow-up is needed to clarify associations reported to date. In particular, 
further evaluation of registered pesticides is warranted.
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responses (Cooper et al. 2004) have also been 
conducted as part of the AHS but are not dis-
cussed in this review.
Methods
We identified studies from the publication 
list on the AHS Web site (Agricultural Health 
Study 2009) and by searching the Medline/
PubMed database (http://www.ncbi.nlm.nih.
gov/sites/entrez?db=pubmed) using the key 
words “Agricultural Health Study” and “pes-
ticides” in combination with various cancer 
types including “leukemia,” “prostate can-
cer,” “colon cancer,” and others. We also 
examined citation lists. Studies were included 
in this review if they were published before 
March 2009 and examined the relationship 
between pesticides and cancer in the AHS 
cohort. Findings related to LDs and/or 
intensity-weighted lifetime-days (IWLDs) of 
pesticide use are the primary focus of this 
review, because these measures allow for the 
evaluation of potential exposure–response 
  relationships.
We identified 28 studies that examined 
the relationship between pesticide exposures 
and cancer incidence in the AHS cohort. A list 
of the pesticides and cancer types examined 
in these studies is provided in Supplemental 
Material (doi:10.1289/ehp.0901731). 
Prevalent cancer cases were excluded in all 
studies reviewed, and incident cases were 
identified by matching cohort members to 
state cancer registry files. Cohort members 
were matched to state death registries and the 
National Death Index to ascertain vital status, 
and current address records of the Internal 
Revenue Service, motor vehicle records, and 
pesticide license registries were used to identify 
cohort members who were alive at the end 
of follow-up but no longer resided in Iowa 
or North Carolina. Follow-up was censored 
at the time of cancer diagnosis, participant 
death, or movement out of state. In gen-
eral, only a small fraction (< 5%) of study 
participants was lost to follow-up. Average 
follow-up times ranged from approximately 4 
to 9 years, and when presented, standardized 
incidence ratios (SIRs) reflect cancer incidence 
in the AHS cohort relative to the populations 
of Iowa and North Carolina using age, sex, 
and race-specific incidence data. The primary 
pesticide exposure measures were LDs (the 
product of days of use per year and years of 
use) and IWLDs (a weighted measure of life-
time exposure-days that accounts for mixing 
conditions, application methods, and the use 
of personal protective equipment) (Dosemeci 
et al. 2002). Where appropriate, a number of 
potential confounding factors were included 
in Poisson/logistic regression models, includ-
ing age, smoking history, alcohol consump-
tion, education, race, sex, applicator type, state 
of residence, LDs of any pesticide exposure, 
pesticides highly correlated with the pesticide 
of interest, family history of cancer, year of 
enrollment, body mass index, sun exposure, 
susceptibility to sunburn, aspirin intake, phys-
ical activity, nonfarm occupational exposures, 
diet, menopausal status, maternal age at first 
birth, age at menarche, and age at menopause. 
Findings were reported as rate ratios (RRs) or 
odds ratios (ORs) and their associated 95% 
confidence intervals (CIs). Linear trend tests 
(alpha = 0.05) were used to evaluate exposure–
response relationships by treating median val-
ues for each pesticide exposure category as a 
quantitative score or by using continuous val-
ues for LDs or IWLDs of exposure. Criteria for 
including a given cancer type in chemical-spe-
cific analyses (i.e., studies of one pesticide and 
multiple cancer types) differed between studies 
and ranged from a minimum total of 5 to 
30 exposed cases. Alternatively, some authors 
specified that a given cancer type was included 
in chemical-specific analyses only if ≥ 4 cases 
were available in each category of exposure. In 
general, pesticides with < 5 exposed applicators 
were excluded from cancer-specific analyses 
(i.e., studies of one cancer type and multiple 
pesticides). Values for the median number 
of exposed cases included in the studies we 
reviewed are listed in Supplemental Material 
(doi:10.1289/ehp.0901731).
Results
Study findings are summarized below for 
individual cancer types examined in the AHS 
cohort to date. Pesticides associated with can-
cer are listed in Table 1. A number of studies 
examined pesticide exposures according to 
both LDs and IWLDs of exposure. RRs (or 
ORs) for both exposure measures are included 
in Table 1 if at least one of these measures 
was associated with a significantly increased 
risk of cancer (p < 0.05). ORs were reported 
by Alavanja et al. (2003, 2004), Andreotti 
et al. (2009), and Lee et al. (2007b), and all 
other studies in Table 1 reported RRs. All 
RRs and ORs in Table 1 refer to nonexposed 
applicators except those reported for alachlor 
and all lymphohematopoietic cancers (Lee 
et al. 2004b), dicamba and colon (Samanic 
et al. 2006), and lung cancer (Alavanja et al. 
2004), which refer to applicators in the lowest 
category of exposure.
Study Summaries
All cancers. Overall cancer incidence was 
increased among applicators in the high-
est exposure categories for diazinon (Beane 
Freeman et al. 2005) and S-ethyl-N,N-
dipropylthiocarbamate (EPTC) (van Bemmel 
et al. 2008) relative to nonexposed applica-
tors, and significant exposure–response 
trends were observed for both pesticides with 
both exposure measures. None of the other 
pesticides examined were associated with a 
significant increase in overall cancer incidence 
(alachlor, atrazine, captan, carbaryl, carbo-
furan, chloro  thalonil, cyanazine, dicamba, 
dichlorvos, fonofos, glyphosate, heptachlor, 
imazethapyr, malathion, metolachlor, pen-
dimethalin, permethrin, phorate, and tri-
fluralin) (Bonner et al. 2005, 2007; De Roos 
et al. 2005a; Greenburg et al. 2008; Hou 
et al. 2006; Kang et al. 2008; Koutros et al. 
2008, 2009; Lee et al. 2004b; Lynch et al. 
2006; Mahajan et al. 2006a, 2006b, 2007; 
Mozzachio et al. 2008; Rusiecki et al. 2004, 
2006, 2009; Samanic et al. 2006).
Lung cancer. Applicators with the high-
est LDs of exposure to chlorpyrifos (Lee 
et al. 2004a), diazinon (Beane Freeman et al. 
2005), dieldrin (Alavanja et al. 2004; Purdue 
et al. 2006), metolachlor (Alavanja et al. 
2004), and pendimethalin (Alavanja et al. 
2004; Hou et al. 2006) had increased lung 
cancer incidence relative to nonexposed appli-
cators. Lung cancer risk was also significantly 
increased among applicators in the highest 
category of intensity-weighted dieldrin expo-
sure days (Purdue et al. 2006), but diazinon 
and pendimethalin were not associated with 
lung cancer when exposures were analyzed 
according to this measure. Applicators with 
the highest LDs of dicamba exposure had 
increased lung cancer incidence relative to 
low-exposed applicators but not relative to 
nonexposed applicators (OR = 1.6; 95% CI, 
0.7–3.4) (Alavanja et al. 2004). Significant 
exposure–response trends were observed 
for chlorpyrifos (Lee et al. 2004a), diazi-
non (Beane Freeman et al. 2005), dicamba 
(Alavanja et al. 2004), dieldrin (Alavanja 
et al. 2004; Purdue et al. 2006), metolachlor 
(Alavanja et al. 2004), and pendimethalin 
(Alavanja et al. 2004). However, the most 
recent study of pendimethalin exposure did 
not observe a significant exposure–response 
trend for lung cancer (Hou et al. 2006). 
Fourteen other pesticides were examined but 
were not associated with increased lung cancer 
incidence in pesticide applicators (atrazine, 
captan, carbaryl, chlorothalonil, cyanazine, 
dichlorvos, EPTC, fonofos, glyphosate, 
imazethapyr, malathion, permethrin, phorate, 
and trifluralin) (Alavanja et al. 2004; Bonner 
et al. 2007; De Roos et al. 2005a; Kang et al. 
2008; Koutros et al. 2008, 2009; Greenburg 
et al. 2008; Mahajan et al. 2006a, 2006b, 
2007; Mozzachio et al. 2008; Lynch et al. 
2006; Rusiecki et al. 2004, 2009; Samanic 
et al. 2006; van Bemmel et al. 2008).
Pancreatic cancer. Applicators in the high-
est categories of intensity-weighted EPTC and 
pendimethalin exposure-days had an increased 
risk of pancreatic cancer relative to nonex-
posed applicators, and we observed significant 
exposure–response trends for both pesticides 
(Andreotti et al. 2009). Eleven other pesti-
cides were examined but were not associated Pesticides and cancer in the Agricultural Health Study
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Table 1. Pesticides associated with cancer in the AHS cohort. 
Cancer type Pesticide(s) Chemical family
Categorical  
exposure cutoff value RR or ORa (95% CI)
p-Value  
for trend References
All cancers Diazinon OP > 109 LDb
Highest IWLDb
1.58 (1.10–2.28)
1.41 (1.03–1.95)
0.007
0.033
Beane Freeman et al. 2005
EPTC Thiocarbamate > 50 LDc
> 112 IWLDc
1.28 (1.09–1.50)
1.16 (1.01–1.35)
< 0.01
0.02
van Bemmel et al. 2008
Lung Chlorpyrifos OP > 56 LDb
> 417 IWLDb
2.18 (1.31–3.64)
1.80 (1.00–3.23)
0.002
0.036
Lee et al. 2004a
Diazinon OP > 109 LDb
Highest IWLDb
3.46 (1.57–7.65)
1.55 (0.65–3.72)
0.001
0.22
Beane Freeman et al. 2005
Dicamba Benzoic acid > 224 LDb 3.10 (1.20–7.70) 0.04 Alavanja et al. 2004
Dieldrin OC > 50 LDb
> 9 LDd
5.30 (1.50–18.6)
2.80 (1.10–7.20)
0.005
0.02 Purdue et al. 2006
Metolachlor Chloroacetanilide Highest IWLDd
> 457 LDb
3.50 (1.60–7.70)
4.10 (1.60–10.4)
0.002
0.015 Alavanja et al. 2004
Pendimethalin Dinitroaniline > 224 LDb
>116 LDb
> 539 IWLDb
3.50 (1.10–10.5)
2.40 (1.10–5.30)
1.10 (0.50–2.60)
0.005
0.29
0.94
Hou et al. 2006
Pancreas EPTC Thiocarbamate > 118 IWLDd 2.50 (1.10–5.40) 0.01 Andreotti et al. 2009
Pendimethalin Dinitroaniline > 117 IWLDd 3.00 (1.30–7.20) 0.01
Colon Aldicarb Carbamate > 56 LDb 4.10 (1.30–12.8) 0.001 Lee et al. 2007a
Dicamba Benzoic acid > 116 LDb
> 739 IWLDb
3.29 (1.40–7.73)
2.57 (1.28–5.17)
0.02
0.002
Samanic et al. 2006
EPTC Thiocarbamate > 50 LDc
> 112 IWLDc
2.09 (1.26–3.47)
2.05 (1.34–3.14)
< 0.01
< 0.01
van Bemmel et al. 2008
Imazethapyr Imidazolinone > 311 IWLD (proximal)b
> 311 IWLD (distal)b
2.73 (1.42–5.25)
1.21 (0.55–2.68)
0.001
0.75
Koutros et al. 2009
Trifluralin Dinitroaniline > 224 LDb
> 1176 IWLDb
1.48 (0.78–2.80)
1.76 (1.05–2.95)
0.12
0.036
Kang et al. 2008
Rectum Chlordane OC > 9 LDd
Highest IWLDd
2.70 (1.10–6.80)
2.10 (0.90–5.30)
0.03
0.04
Purdue et al. 2006
Chlorpyrifos OP > 56 LDb
> 417 IWLDb
>109 LDb
3.25 (1.60–6.62)
3.16 (1.42–7.03)
2.70 (1.20–6.40)
0.035
0.057
0.008
Lee et al. 2004a
Lee et al. 2007a
Pendimethalin Dinitroaniline > 116 LDc
> 539 IWLDc
4.30 (1.50–12.7)
3.60 (1.20–11.3)
0.007
0.02
Hou et al. 2006
Toxaphene OC > 56 LDb 4.30 (1.20–15.8) 0.123 Lee et al. 2007a
Leukemia Chlordane/Heptachlor OC > 9 LDd
Highest IWLDd
2.60 (1.20–6.00)
2.10 (0.80–5.50)
0.02
0.10
Purdue et al. 2006
Chlorpyrifos OP > 56 LDb
> 417 IWLDb
2.15 (0.96–4.81)
3.01 (1.35–6.69)
0.36
0.15
Lee et al. 2004a
Diazinon OP > 39 LDc
Highest IWLDc
3.36 (1.08–10.5)
2.88 (0.92–9.03)
0.026
0.053
Beane Freeman et al. 2005
EPTC Thiocarbamate > 50 LDc
> 112 IWLDc
2.36 (1.16–4.84)
1.87 (0.97–3.59)
0.02
0.05
van Bemmel et al. 2008
Fonofos OP > 609 IWLDc 2.67 (1.06–6.70) 0.04 Mahajan et al. 2006a
All LH Alachlor Chloroacetanilide > 116 LDc
> 710 IWLDc
2.04 (0.89–4.65)
2.42 (1.00–5.89)
0.02
0.03
Lee et al. 2004b
Chlorpyrifos OP > 56 LDb
> 417 IWLDb
1.43 (0.86–2.36)
1.99 (1.22–3.26)
0.26
0.09
Lee et al. 2004a
Diazinon OP > 39 LDc
Highest IWLDc
1.84 (0.89–3.82)
2.01 (1.02–3.94)
0.094
0.049
Beane Freeman et al. 2005
Permethrin Pyrethroid > 50 LDc
> 220 IWLDc
1.64 (1.07–2.52)
1.31 (0.84–2.04)
0.35
0.60
Rusiecki et al. 2009
NHL Lindane OC > 22 LDd
Highest IWLDd
2.10 (0.80–5.50)
2.60 (1.10–6.40)
0.12
0.04
Purdue et al. 2006
Multiple myeloma Permethrin Pyrethroid > 50 LDc
> 220 IWLDc
5.72 (2.76–11.8)
5.01 (2.41–10.4)
< 0.01
< 0.01
Rusiecki et al. 2009
Bladder Imazethapyr Imidazolinone > 311 IWLDb 2.37 (1.20–4.68) 0.01 Koutros et al. 2009
Prostate Fonofos OP > 56 LDc
> 315 IWLDc
1.77 (1.03–3.05)
1.83 (1.12–3.00)
0.02
0.01
Mahajan et al. 2006a (for applicators 
with a family history of prostate cancer)
Methylbromide Halogenated alkane Highest IWLDe 3.47 (1.37–8.76) 0.004 Alavanja et al. 2003
Brain Chlorpyrifos OP > 56 LDb
> 417 IWLDb
2.58 (0.73–9.17)
4.03 (1.18–13.8)
0.076
0.036
Lee et al. 2004a
Melanoma Carbaryl Carbamate > 175 LDb
Highest intensity scoreb
4.11 (1.33–12.7)
1.54 (0.61–3.86)
0.07
0.92
Mahajan et al. 2007
Toxaphene OC > 25 LDd
Highest IWLDd
2.90 (1.10–8.10)
1.80 (0.70–5.10)
0.03
0.24
Purdue et al. 2006
Abbreviations: LH, lymphohematopoietic cancers; OC, organochlorine; OP, organophosphate. ORs were reported by Alavanja et al. (2003, 2004), Andreotti et al. (2009), and Lee et al. 
(2007b); all others are RRs. 
aAll RRs and ORs were estimated relative to nonexposed applicators except those reported for alachlor and all LH (Lee et al. 2004b) and dicamba and colon (Samanic et al. 2006) and 
lung cancer (Alavanja et al. 2004), which are in reference to applicators in the lowest category of exposure. bHighest quintile. cHighest quartile. dHighest tertile. eHighest sixth.Weichenthal et al.
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with pancreatic cancer [alachlor, atrazine, 
chlorpyrifos, cyanazine, 2,4-dichlorophenoxy 
acetic acid (2,4-D), dicamba, glyphosate, 
imazethapyr, metolachlor, terbufos, and tri-
fluralin] (Andreotti et al. 2009; De Roos et al. 
2005a; Rusiecki et al. 2004).
Colon and rectal cancer. Applicators with 
the highest LDs of exposure to aldicarb (Lee 
et al. 2007b), dicamba (Samanic et al. 2006), 
EPTC (van Bemmel et al. 2008), imazethapyr 
(Koutros et al. 2009), and trifluralin (Kang 
et al. 2008) had increased colon cancer inci-
dence relative to nonexposed applicators. For 
imazethapyr, excess colon cancer incidence 
was limited to the proximal colon (Koutros 
et al. 2009); other studies did not examine 
colon cancer according to location. Significant 
exposure–response relationships were observed 
for aldicarb, dicamba, EPTC, imazethapyr, 
and trifluralin, but few cases were available 
in the first (n = 7) and second tertiles (n = 4) 
of intensity-weighted EPTC exposure days. 
Applicators with the highest lifetime expo-
sure-days for chlordane (Purdue et al. 2006), 
chlorpyrifos (Lee et al. 2004a; 2007b), pen-
dimethalin (Hou et al. 2006), and toxaphene 
(Lee et al. 2007b) had increased rectal cancer 
risk relative to nonexposed applicators. Rectal 
cancer risk was also significantly increased 
when chlorpyrifos and pendimethalin expo-
sures were analyzed according to IWLDs 
(Hou et al. 2006; Lee et al. 2004a), and 
we observed significant exposure–response 
trends for chlordane (Purdue et al. 2006), 
chlorpyrifos (Lee et al. 2004a; 2007b), and 
pendimethalin (Hou et al. 2006). Seventeen 
other pesticides were examined but were not 
associated with colon or rectal cancer inci-
dence (2,4-D, alachlor, aldrin, atrazine, cap-
tan, carbaryl, carbofuran, chlorothalonil, 
cyanazine, diazinon, dichlorvos, fonofos, gly-
phosate, malathion, metolachlor, permethrin, 
and phorate) (Beane Freeman et al. 2005; 
Bonner et al. 2005, 2007; De Roos et al. 
2005a; Greenburg et al. 2008; Koutros et al. 
2008; Lee et al. 2004b, 2007b; Lynch et al. 
2006; Mahajan et al. 2006a, 2007; Mozzachio 
et al. 2008; Purdue et al. 2006; Rusiecki et al. 
2004, 2006, 2009).
All  lymphohematopoietic  cancers. 
Applicators in the highest category of inten-
sity-weighted alachlor exposure-days had an 
increased incidence of all lymphohemato-
poietic cancers relative to low-exposed appli-
cators (Lee et al. 2004b). Applicators in the 
highest categories of intensity-weighted expo-
sure-days for chlorpyrifos (Lee et al. 2004a) 
and diazinon (Beane Freeman et al. 2005) had 
an increased incidence of all lympho  hemato-
poietic cancers relative to nonexposed applica-
tors, but RRs were not significantly increased 
when exposures were analyzed according to 
LDs of use. Applicators in the highest category 
of permethrin exposure-days had an increased 
incidence of all lymphohematopoietic can-
cers but the RR for the highest category of 
intensity-weighted permethrin exposure-days 
was not significantly increased (Rusiecki et al. 
2009). Significant exposure–response trends 
were observed for alachlor (Lee et al. 2004b) 
and diazinon (Beane Freeman et al. 2005). 
Fifteen other pesticides were examined but 
were not associated with lymphohemato-
poietic cancers (captan, carbaryl, carbofuran, 
cyanazine, dicamba, dichlorvos, EPTC, 
fonofos, glyphosate, imazethapyr, malathion, 
metolachlor, pendimethalin, phorate, and tri-
fluralin) (Bonner et al. 2005, 2007; De Roos 
et al. 2005a; Greenburg et al. 2008; Hou et al. 
2006; Kang et al. 2008; Koutros et al. 2008, 
2009; Lee et al. 2004b; Lynch et al. 2006; 
Mahajan et al. 2006a, 2006b, 2007; Rusiecki 
et al. 2006; Samanic et al. 2006).
Leukemia. Applicators with the highest 
LDs of exposure for heptachlor/  chlordane 
(Purdue et al. 2006), diazinon (Beane Freeman 
et al. 2005), and EPTC (van Bemmel et al. 
2008) had increased leukemia incidence 
relative to nonexposed applicators. When 
exposures were analyzed according to inten-
sity-weighted exposures-days, applicators in 
the highest categories of exposure for fono-
fos (Mahajan et al. 2006a) and chlorpyrifos 
(Lee et al. 2004a) also had increased leukemia 
incidence relative to nonexposed applicators. 
Significant dose–response relationships were 
observed for heptachlor/chlordane, diazinon, 
EPTC, and fonofos. Seven other pesticides 
were examined but were not associated with 
leukemia in pesticide applicators (alachlor, 
atrazine, carbaryl, glyphosate, imazethapyr, 
malathion, and trifluralin) (Bonner et al. 
2007; De Roos et al. 2005a; Kang et al. 2008; 
Koutros et al. 2009; Mahajan et al. 2007; 
Rusiecki et al. 2004, 2009).
Non-Hodgkin lymphoma. Applicators in 
the highest category of intensity-weighted 
exposure-days for lindane had increased 
non-Hodgkin lymphoma (NHL) incidence 
relative to nonexposed applicators, and a 
significant exposure–response trend was 
observed (Purdue et al. 2006). However, we 
did not observe a significant trend for lin-
dane when we analyzed exposures according 
to lifetime exposure-days. Sixteen other pes-
ticides were examined but were not associated 
with NHL in pesticide applicators (alachlor, 
atrazine, carbaryl, carbofuran, chlorpyrifos, 
cyanazine, diazinon, dicamba, EPTC, gly-
phosate, imazethapyr, malathion, metolachlor, 
pendimethalin, permethrin, and trifluralin) 
(Beane Freeman et al. 2005; Bonner et al. 
2005, 2007; De Roos et al. 2005a; Hou 
et al. 2006; Kang et al. 2008; Koutros et al. 
2009; Lee et al. 2004a, 2004b; Lynch et al. 
2006; Mahajan et al. 2007; Rusiecki et al. 
2004, 2006, 2009; Samanic et al. 2006; van 
Bemmel et al. 2008).
Multiple myeloma. Applicators in the 
highest categories of permethrin exposure had 
an increased incidence of multiple myeloma 
relative to nonexposed applicators, and we 
observed significant exposure–response pat-
terns (Rusiecki et al. 2009). However, ≤ 3 cases 
were available in the first and second tertiles 
of exposure; further evaluation of a potential 
exposure–response pattern is required once 
more cases have accrued. Four other pesticides 
were examined but were not associated with 
multiple myeloma (alachlor, atrazine, chlor-
pyrifos, and glyphosate) (De Roos et al. 2005a; 
Lee et al. 2004a, 2004b; Rusiecki et al. 2004).
Breast cancer. Engel et al. (2005) examined 
breast cancer incidence among farmers’ wives. 
Breast cancer incidence was decreased among 
women who reported ever applying pesticides 
relative to the general population (SIR = 0.87; 
95% CI, 0.89–1.24), and strong associations 
were not detected for specific pesticides. Ever 
use of pesticides in this study included use 
on crops and livestock as well as use in the 
home or garden. Although few women per-
sonally applied many of the pesticides exam-
ined, breast cancer incidence was increased 
among women whose husbands reported ever 
use of aldrin (RR = 1.9; 95% CI, 1.3–2.7), 
carbaryl (RR = 1.4; 95% CI, 1.0–2.0), chlor-
dane (RR = 1.7; 95% CI, 1.2–5.5), dieldrin 
(RR = 2.0; 95% CI, 1.1–3.3), heptachlor (RR 
= 1.6; 95% CI, 1.1–2.4), lindane (RR = 1.7; 
95% CI, 1.1–2.5), malathion (RR = 1.4; 95% 
CI, 1.0–2.0), 2,4,5-trichloro  phenoxypropionic 
acid (2,4,5-TP) (RR = 2.0; 95% CI, 1.2–3.2) 
or captan (RR = 2.7; 95% CI, 1.7–4.3). RRs 
varied by menopausal status, with increased 
breast cancer incidence observed among pre-
menopausal women ever exposed to chlor-
pyrifos (RR = 2.2; 95% CI, 1.0– 4.9), 
dichlorvos (RR = 2.3; 95% CI, 1.0–5.3), or 
terbufos (RR = 2.6; 95% CI, 1.1–5.9) but 
not among postmenopausal women. Potential 
exposure–response patterns were not examined 
in this study because pesticide exposure infor-
mation was limited to ever/never use data. 
Other studies of pesticide exposure and breast 
cancer incidence in the AHS cohort have not 
been conducted to date.
Bladder cancer. Applicators in the highest 
category of intensity-weighted imazethapyr 
exposure-days had an increased incidence of 
bladder cancer relative to nonexposed appli-
cators, and a significant exposure–response 
pattern was observed (Koutros et al. 2009). 
Nine other pesticides were examined but were 
not associated with bladder cancer in pesti-
cide applicators (alachlor, atrazine, carbaryl, 
dicamba, EPTC, glyphosate, malathion, per-
methrin, and trifluralin) (Bonner et al. 2007; 
De Roos et al. 2005a; Kang et al. 2008; Lee 
et al. 2004b; Mahajan et al. 2007; Rusiecki 
et al. 2004, 2009; Samanic et al. 2006; van 
Bemmel et al. 2008).Pesticides and cancer in the Agricultural Health Study
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Prostate cancer. Applicators in the high-
est categories of fonofos exposure who also 
had a family history of prostate cancer had 
increased prostate cancer incidence relative 
to nonexposed applicators (Mahajan et al. 
2006a). Significant exposure–response pat-
terns were observed for both exposure mea-
sures, and the reported findings suggest that a 
family history of prostate cancer may modify 
prostate cancer risk in applicators exposed to 
fonofos. Applicators in the highest categories 
of fonofos exposure without a family his-
tory of prostate cancer did not have increased 
prostate cancer incidence (RRLD = 0.86; 95% 
CI, 0.60–1.24; RRIWLD = 0.96; 95% CI, 
0.70–1.31). Applicators in the highest cat-
egory of intensity-weighted exposure-days 
for methyl bromide had increased prostate 
cancer risk relative to nonexposed applica-
tors, and a significant exposure–  response 
trend was observed (Alavanja et al. 2003). 
Twenty-three other pesticides were exam-
ined but were not associated with prostate 
cancer (alachlor, aldrin, atrazine, captan, 
carbo  furan, carbaryl, chlorothalonil, chlorpy-
rifos, cyanazine, DDT, diazinon, dicamba, 
dichlorvos, EPTC, glyphosate, heptachlor, 
imazethapyr, malathion, metolachlor, pen-
dimethalin, permethrin, phorate, and triflu-
ralin) (Alavanja et al. 2003; Beane Freeman 
et al. 2005; Bonner et al. 2005, 2007; De 
Roos et al. 2005a; Greenburg et al. 2008; 
Hou et al. 2006; Kang et al. 2008; Koutros 
et al. 2008, 2009; Lynch et al. 2006; Mahajan 
et al. 2006b, 2007; Mozzachio et al. 2008; 
Rusiecki et al. 2004, 2006, 2009; Samanic 
et al. 2006; van Bemmel et al. 2008).
Brain cancer. Lee et al. (2004a) examined 
brain cancer incidence in pesticide applicators 
exposed to chlorpyrifos. Applicators in the 
highest category of intensity-weighted chlo-
rpyrifos exposure-days had increased brain 
cancer incidence relative to nonexposed appli-
cators, and a significant exposure–response 
pattern was observed. However, findings were 
based on small numbers of exposed cases 
(2 ≤ n ≤ 7) and the exposure–response trend 
was not monotonic, as the second-highest 
exposure group had a lower risk of brain can-
cer (RR = 1.25; 95% CI, 0.26–6.10) than 
applicators in the lowest category of exposure 
(RR = 3.32; 95% CI, 0.98–11.24). Elevated 
RRs were reported for the two highest catego-
ries of chlorpyrifos exposure-days, but these 
estimates were not significantly increased and 
a significant exposure–response trend was not 
observed. Other studies of pesticide exposure 
and brain cancer incidence in the AHS cohort 
have not been conducted to date.
Melanoma. Applicators in the highest 
categories of lifetime carbaryl (Mahajan et al. 
2007) and toxaphene (Purdue et al. 2006) 
exposure-days had an increased incidence of 
melanoma relative to nonexposed applicators. 
Significant exposure–response patterns were 
not observed for carbaryl when exposures were 
analyzed according to lifetime exposure-days 
or intensity-weighted exposure-days (Mahajan 
et al. 2007). We observed a significant expo-
sure–response trend with increasing LDs of 
toxaphene exposure but not when exposures 
were analyzed according to intensity-weighted 
exposure-days. Ten other pesticides were exam-
ined but were not associated with melanoma 
incidence in pesticide applicators (atrazine, 
diazinon, dicamba, EPTC, fonofos, glyphosate, 
imazethapyr, malathion, pendimethalin, and 
permethrin) (Beane Freeman et al. 2005; 
Bonner et al. 2007; De Roos et al. 2005a; Hou 
et al. 2006; Koutros et al. 2009; Mahajan et al. 
2006a; Rusiecki et al. 2004, 2009; Samanic 
et al. 2006; van Bemmel et al. 2008).
Other cancers. Kidney cancer. Six stud-
ies examined the relationship between pesti-
cide exposure and kidney cancer in pesticide 
applicators, but strong associations were not 
observed for any of the pesticides examined 
(atrazine, chlorpyrifos, glyphosate, imazethapyr, 
malathion, and trifluralin) (Bonner et al. 
2007; De Roos et al. 2005a; Kang et al. 2008; 
Koutros et al. 2009; Lee et al. 2004a; Rusiecki 
et al. 2004). Increased RRs were reported for 
applicators in the highest categories of triflura-
lin exposure relative to nonexposed applicators 
(RRLD = 2.06; 95% CI, 0.75–5.65; RRIWLD 
= 1.77; 95% CI, 0.73–4.30), but these esti-
mates were not significantly increased, and 
significant exposure–response trends were not 
observed for either exposure measure (Kang 
et al. 2008).
Childhood cancer. Flower et al. (2004) 
examined cancer incidence in children of male 
farmers in Iowa. Overall cancer incidence was 
increased among children of pesticide applica-
tors (SIR = 1.36; 95% CI, 1.03–1.79), and 
more lymphoma (SIR = 2.18; 95% CI, 1.13– 
4.19) and Hodgkin lymphoma (SIR = 2.56; 
95% CI, 1.06–6.14) cases were observed than 
expected based on childhood cancer rates in 
the Iowa population. However, SIRs for spe-
cific cancers were based on small numbers of 
cases (2 ≤ n ≤ 11). Cancer risk was increased 
among children whose fathers did not use 
chemically resistant gloves when mixing pes-
ticides relative to children with fathers who 
wore gloves (OR = 1.98; 95% CI, 1.05–3.76). 
In addition, relative to children of nonexposed 
men, children whose fathers used aldrin dur-
ing the prenatal period also had an increased 
cancer risk (OR = 2.66; 95% CI, 1.08–6.59). 
Potential exposure–response patterns were not 
examined for specific pesticides, however, and 
15 other pesticides examined in this study 
were not associated with childhood cancer 
(alachlor, atrazine, chlorpyrifos, cyanazine, 
2,4-D, dichlorvos, dicamba, EPTC, gly-
phosate, malathion, metolachlor, metribuzin, 
phorate, trifluralin, and terbufos).
Miscellaneous. Several studies examined 
the relationship between pesticide exposures 
and oral cavity cancers (De Roos et al. 2005a; 
Koutros et al. 2009; Rusiecki et al. 2004, 
2006), stomach cancer (Lee et al. 2004b), 
esophagus cancer (Lee et al. 2004a; Rusiecki 
et al. 2004), and thyroid cancer (Lee et al. 
2004b), but none of the six pesticides exam-
ined were associated with increased risk of these 
types of cancers (alachlor, atrazine, chlorpyri-
fos, glyphosate, imazethapyr, and metolachlor).
Discussion
Through March 2009, 27 studies examined 
the relationship between LDs or IWLDs of 
pesticide exposure and cancer incidence in 
the AHS cohort. Thirty-two different pes-
ticides were included in these studies, and 
most study participants personally applied 
pesticides for 11– 30 years before enrollment 
(Alavanja et al. 2005). When appropriate, all 
studies adjusted for the use of pesticides cor-
related with the specific pesticide of interest; 
however, it is possible that this adjustment did 
not completely isolate the independent effects 
of each individual pesticide or eliminate the 
impact of multiple exposures. Nonetheless, 
findings from Coble et al. (2002) suggest that 
the magnitude of bias due to confounding 
from exposure to multiple agents is likely to 
be minimal based on the proportion of farm-
ers reporting exposure to agents including 
cleaning solvents and diesel exhaust. Findings 
of chemical cohort analyses (i.e., studies of 
a single pesticide and multiple cancer types) 
and cancer site analyses (i.e., studies of 
a single cancer type and multiple pesticide 
exposures) were generally consistent with 
respect to the magnitude and direction of the 
observed associations. Specifically, chemical 
cohort and cancer site analysis were consis-
tent for carbaryl and colon cancer (no associa-
tion) (Lee et al. 2007b; Mahajan et al. 2007), 
chlorpyrifos and rectal cancer (significantly 
increased risk) (Lee et al. 2004a, 2007b), pen-
dimethalin, permethrin, and colorectal cancer 
(no association) (Hou et al. 2006; Lee et al. 
2007b; Rusiecki et al. 2009), carbofuran, 
chlorpyrifos, diazinon, dieldrin, pendimetha-
lin, and lung cancer (significantly increased 
risk) (Alavanja et al. 2004; Beane Freeman 
et al. 2005; Bonner et al. 2005; Hou et al. 
2006; Lee et al. 2004a; Purdue et al. 2006), 
dicamba and lung cancer (no association 
with nonexposed reference group) (Alavanja 
et al. 2004; Samanic et al. 2006), atrazine, 
glyphosate, and pancreatic cancer (no asso-
ciation) (Andreotti et al. 2009; De Roos et al. 
2005a; Rusiecki et al. 2004), and atrazine, 
captan, carbofuran, permethrin, and pros-
tate cancer (no association) (Alavanja et al. 
2003; Bonner et al. 2005; Greenburg et al. 
2008; Rusiecki et al. 2004, 2009). Findings 
of Lee et al. (2007b) and Purdue et al. (2006) Weichenthal et al.
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were somewhat inconsistent with respect to 
the relationship between chlordane and rec-
tal cancer. Specifically, Purdue et al. (2006) 
reported an increased RR for applicators with 
> 9 LDs of chlordane exposure, whereas Lee 
et al. (2007b) did not observe increased rectal 
cancer incidence among applicators with > 56 
days of exposure. However, in the analysis 
conducted by Lee et al. (2007b), only two 
exposed cases were available in the highest 
exposure group (> 56 LDs), and rectal can-
cer incidence was increased among applica-
tors with 20–56 days of chlordane exposure. 
Therefore, both studies provide evidence of 
an association between chlordane and rectal 
cancer even though Lee et al. (2007b) did 
not observe an increased OR in the highest 
category of exposure. Chemical cohort analy-
sis for metolachlor (Rusiecki et al. 2006) did 
not confirm the previously observed associa-
tion with lung cancer (Alavanja et al. 2004). 
One explanation for this discrepancy may 
be that the association reported by Alavanja 
et al. (2004) occurred by chance, as find-
ings were based on fewer exposed cases and 
were less precise. Alternatively, differences 
in cutoff points used for the highest expo-
sure groups may explain this inconsistency; 
a value of 457 LDs was used by Alavanja 
et al. (2003), whereas a value of 116 LDs 
was used by Rusiecki et al. (2006). Therefore, 
it is possible that an increased RR was not 
reported by Rusiecki et al. (2006) because 
the highest exposure group included applica-
tors with exposure levels below those likely 
to result in increased cancer risk. This pos-
sibility is supported by the fact that Alavanja 
et al. (2003) did not observe an associa-
tion between metolachlor and lung cancer 
among applicators exposed for 116–457 
LDs. Finally, increased risks of colon can-
cer observed in chemical specific analyses for 
dicamba (Samanic et al. 2006) and trifluralin 
(Kang et al. 2008) do not agree with findings 
reported in cancer-specific analyses (Lee et al. 
2007b). However, analyses for dicamba and 
trifluralin were limited to ever/never expo-
sure classification in the study by Lee et al. 
(2007b), whereas Samanic et al. (2006) and 
Kang et al. (2008) reported increased RRs 
for colon cancer when exposures were ana-
lyzed according to intensity-weighted expo-
sure days. Therefore, differences in exposure 
classification may account for discrepancies 
observed between these studies.
In total, 19 pesticides were associated with 
a significantly increased risk of at least one 
type of cancer. Clear similarities by type (i.e., 
insecticide, herbicide, or fungicide), chemical 
structure, or chemical family were not appar-
ent among these pesticides (Table 1). Seven 
of these 19 pesticides are no longer regis-
tered for use in Canada or the United States 
(chlordane, dieldrin, fonofos, heptachlor, lin-
dane, methyl bromide, and toxaphene), and 
three additional pesticides, alachlor, aldicarb, 
and metolachlor, are registered for use in the 
United States but are not registered in Canada. 
Of the remaining pesticides currently regis-
tered for use in Canada or the United States, 
statistically significant exposure–response 
trends were observed for alachlor (all lym-
phohematopoietic), aldicarb (colon), carbaryl 
(melanoma), chlorpyrifos (lung, rectal), diazi-
non (all cancers, all lympho  hemato  poietic, 
leukemia, lung), dicamba (colon, lung), EPTC 
(all cancers, colon, pancreas), imazethapyr 
(bladder, colon), metolachlor (lung), pendi-
methalin (lung, pancreas, rectal), permethrin 
(multiple myeloma), and tri  fluralin (colon) 
(Alavanja et al. 2004; Andreotti et al. 2009; 
Beane Freeman et al. 2005; Hou et al. 2006; 
Kang et al. 2008; Koutros et al. 2009; Lee 
et al. 2004a, 2004b, 2007b; Mahajan et al. 
2007; Rusiecki et al. 2006, 2009; Samanic 
et al. 2006; van Bemmel et al. 2008). These 
pesticides are listed in Table 2 along with ani-
mal toxicologic evidence of carcinogenicity 
noted by the U.S. EPA (2007), Canadian Pest 
Management Regulatory Agency (PMRA) 
(Health Canada 2003, 2005, 2007, 2008), 
and the International Agency for Research on 
Cancer (IARC 2010). The U.S. EPA classifica-
tion terms “likely” and “not likely” in Table 2 
do not correspond to quantifiable probabili-
ties of carcinogenicity but instead reflect the 
weight of animal toxicologic evidence for or 
against such a relationship (i.e., a classification 
of “likely” does not mean that a given pesticide 
is a confirmed carcinogen, but only that such 
an effect is plausible give current toxicologic 
evidence).
The IARC has not evaluated most pes-
ticides listed in Table 2 (alachlor, chlorpyri-
fos, diazinon, dicamba, EPTC, imazethapyr, 
metolachlor, pendimethalin, and trifluralin) 
and considers the remaining pesticides (aldi-
carb, carbaryl, and permethrin) not classifi-
able with respect to human carcinogenicity 
(group 3). Evidence of carcinogenicity was 
noted by the U.S. EPA and/or PMRA in 
animal toxicity studies for alachlor, carbaryl, 
metolachlor, pendimethalin, permethrin, and 
trifluralin, thus supporting the biological plau-
sibility of associations observed for these pes-
ticides. The remaining registered pesticides for 
which exposure–response relationships were 
observed are not considered carcinogenic by 
the U.S. EPA or PMRA (aldicarb, chlorpyrifos, 
diazinon, dicamba, EPTC, and imazethapyr).
Risk estimates were imprecise for most 
registered pesticides that displayed an 
  exposure–response pattern with at least one 
type of cancer because of small numbers of 
exposed cases. Specifically, ≤ 12 cases were 
available in the highest categories of exposure 
Table 2. Evidence of carcinogenicity noted as of March 2009 by the U.S. EPA, PMRA, and IARC for registered pesticides that displayed a significant exposure–
response relationship with at least one type of cancer.
Pesticide Type
Cancer type(s) with  
exposure–response 
in the AHS cohort
Organization
U.S. EPA PMRA IARC
Alachlor (Lee et al. 2004b) Herbicide All LH Likely (high doses) /
not likely (low doses)
Not registered in Canada Not evaluated
Aldicarb (Lee et al. 2007a) Insecticide Colon Group Ea  Not registered in Canada Group 3b
Carbaryl (Mahajan et al. 2007) Insecticide Melanoma Likely Under re-evaluation (positive)c Group 3b
Chlorpyrifos (Lee et al. 2004a, 2007b) Insecticide Lung, rectum Group Ea Negatived Not evaluated
Diazinon (Alavanja et al. 2004; Beane Freeman et al. 
2005)
Insecticide All cancers, all LH, 
leukemia, lung
Not likely Negatived Not evaluated
Dicamba (Alavanja et al. 2004; Samanic et al. 2006) Herbicide Colon, lung Not likely Negatived Not evaluated
EPTC (Andreotti et al. 2009; van Bemmel et al. 2008) Herbicide All cancers, colon, 
leukemia, pancreas
Not likely Negatived Not evaluated
Imazethapyr (Koutros et al. 2009) Herbicide Bladder, colon Not likely Under re-evaluation (negative)d Not evaluated
Metolachlor (Alavanja et al. 2004) Herbicide Lung Group Ce Not registered in Canada Not evaluated
Pendimethalin (Alavanja et al. 2004; Andreotti et al. 
2009; Hou et al. 2006)
Herbicide Lung, rectum, 
pancreas
Group Ce Positivec Not evaluated
Permethrin (Rusiecki et al. 2006, 2009) Insecticide Myeloma Likely Positivec Group 3b
Trifluralin (Kang et al. 2008) Herbicide Colon Group Ce Positivec Not evaluated
aEvidence of noncarcinogenicity in humans. bNot classifiable as to carcinogenicity to humans. cEvidence of carcinogenicity noted in animal toxicology database. dNo evidence of 
  carcinogenicity in animal toxicology database. ePossible human carcinogen. Pesticides and cancer in the Agricultural Health Study
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for aldicarb (colon), carbaryl (melanoma), 
chlor  pyrifos (rectal), diazinon (all LH, leuke-
mia, lung), dicamba (lung), EPTC (pancreas), 
imazethapyr (colon, bladder), metolachlor 
(lung), pendimethalin (lung, pancreas, rec-
tal), and permethrin (multiple myeloma). As 
a result, little can be concluded at this time 
regarding the causal nature of these associa-
tions, and further analyses are required once 
more cases have accrued. RRs for chlorpyrifos 
and lung cancer and EPTC and colon cancer 
were more precise, each indicating that can-
cer incidence doubled in the highest expo-
sure groups relative to nonexposed applicators 
(Lee et al. 2004a; van Bemmel et al. 2008). 
However, the weight of biological evidence 
reviewed by the U.S. EPA and PMRA does 
not suggest that chlorpyrifos and EPTC are 
carcinogenic (Health Canada 2003, 2008; 
Smegal 2002; U.S. EPA 1999). One expla-
nation for discrepancies between AHS find-
ings and toxicologic evidence may be that 
animal toxicity tests typically reflect exposure 
to a single pesticide active ingredient and not 
the end-use product or multiple products. 
Therefore, real-life exposures in the field are 
not equivalent to what is tested in animal tox-
icity studies. Alternatively, some AHS find-
ings may have occurred by chance because 
of the large number of multiple comparisons 
or bias from uncontrolled confounding or 
other source of bias. Nevertheless, as many 
of the studies reviewed are the first to exam-
ine the reported associations, the findings are 
useful for generating hypotheses that require 
confirmation in future studies. Going for-
ward, adjustment for multiple comparisons 
will be important to avoid spurious associa-
tions. Likewise, bias analysis may be helpful 
in characterizing overall uncertainty in AHS 
findings; a recent study by Lash (2007) illus-
trates how conventional frequentist methods 
may understate uncertainty in effect measures 
by quantifying only random error and may 
result in bias away from the null.
Epidemiologic evidence outside the AHS 
cohort remains limited with respect to asso-
ciations observed for specific pesticides and 
cancer types listed in Table 2. Three stud-
ies examined cancer incidence in a cohort 
of alachlor manufacturing workers in Iowa 
(Acquavella et al. 1996, 2004; Leet et al. 
1996). Lymphohematopoietic tumors were 
increased in one of these studies relative to 
expected values in the Iowa population (SIR 
= 3.6; 95% CI, 1.2–8.5) (Leet et al. 1996); 
however, this estimate was based on only five 
exposed cases, and potential confounding fac-
tors were not included in the analyses. Two or 
fewer lymphohematopoietic cancer cases were 
available in studies conducted by Acquavella 
et al. (1996, 2004), and in general, none of 
the three studies of alachlor manufactur-
ing workers provides strong evidence of an 
important relationship between alachlor and 
cancer. Studies of carbaryl and melanoma 
have not been conducted outside the AHS 
cohort, but Zheng et al. (2001) reported an 
association between small-cell lymphoma 
among participants exposed to carbaryl in a 
pooled analysis of three case–control studies 
in the United States (Cantor et al. 1992; Hoar 
et al. 1986; Zahm et al. 1990). However, car-
baryl exposure was not associated with NHL 
in a Canadian case–control study after adjust-
ing for a number of potential confounding 
factors (McDuffie et al. 2001), and carbaryl 
was not associated with NHL in the AHS 
cohort (Mahajan et al. 2007). A case–control   
study examined lung cancer mortality in 
Florida pest control workers exposed to chlor-
pyrifos and diazinon, but neither pesticide 
was associated with a significantly increased 
risk of lung cancer mortality (Pesatori et al. 
1994). Chlorpyrifos and diazinon were iden-
tified as possible risk factors for NHL in a 
pooled analysis of three case–control studies 
in Iowa, Minnesota, Kansas, and Nebraska 
(Waddell et al. 2001); however, these pesti-
cides were not associated with NHL in the 
AHS cohort (Beane Freeman et al. 2005; Lee 
et al. 2004a). One previous case–control study 
observed an association between dicamba and 
NHL (McDuffie et al. 2001), but dicamba 
was not associated with NHL in the AHS 
cohort. Hoar et al. (1986) noted an associa-
tion between NHL and trifluralin exposure 
based on only three exposed cases, but a more 
recent pooled analysis did not observe a sig-
nificant relationship between trifluralin and 
NHL (De Roos et al. 2003). Previous studies 
of chlorpyrifos and rectal cancer and diazinon 
and leukemia were not identified. Likewise, 
studies of aldicarb, dicamba, and colon can-
cer, EPTC and colon or pancreatic cancer, 
imazethapyr and bladder or colon cancer, 
metolachlor and lung cancer, pendimethalin 
and lung, rectal, or pancreatic cancer, per-
methrin and myeloma, and trifluralin and 
colon cancer were not identified outside the 
AHS cohort, and epidemiologic evidence in 
general is limited for these pesticides.
Exposure assessment is a challenge in 
large-scale epidemiologic studies, as it is often 
not possible to obtain quantitative exposure 
data at etiologically relevant time periods for 
large numbers of study participants. In the 
AHS, self-reported LDs and IWLDs of pesti-
cide exposure are used as the primary exposure 
measures. To date, four studies have examined 
the validity of the intensity-weighted exposure 
algorithm used in the AHS (Acquavella et al. 
2006; Coble et al. 2005; Thomas et al. 2009). 
Two of these studies were conducted using 
data from the Pesticide Exposure Assessment 
Study conducted in Canada (Acquavella et al. 
2006; Coble et al. 2005), and the remaining 
two studies were conducted using members of 
the AHS cohort (Hines et al. 2008; Thomas 
et al. 2009). In general, validation studies 
have observed low to moderate correlations 
between exposure intensity algorithm scores 
and urinary biomarkers of 2,4-D, 4-chloro-2-
methylphenoxyacetic acid (MCPA), captan, 
glyphosate, and chlorpyrifos (Acquavella et al. 
2006; Coble et al. 2005; Hines et al. 2008; 
Thomas et al. 2009). Low to moderate corre-
lations were also reported between algorithm 
scores and quantitative levels of 2,4-D and 
chlorpyrifos measured in hand-wipe samples, 
dermal patches, and personal air samples 
(Thomas et al. 2009); however, correlations 
between algorithm scores and quantitative 
measures of chlorpyrifos exposure varied by 
application method, with stronger correlations 
observed for liquid spray applications relative 
to granular in-furrow applications. For cap-
tan, intensity-weighted algorithm scores were 
predictive of exposure levels measured on der-
mal patch samples located on the thighs of 
pesticide applicators but were not significant 
predictors of captan levels measured in per-
sonal air samples, hand rinses, and forearm 
patches (Hines et al. 2008). Weighted kappa 
values for categorical agreement between algo-
rithm scores and biomarker levels were low 
to moderate (0.07 < kappa < 0.37) in valida-
tion studies conducted to date, and consider-
able overlap in urinary biomarker levels was 
apparent between exposure categories based 
on algorithm scores (Acquavella et al. 2006; 
Thomas et al. 2009). However, algorithm 
scores were able to detect significant trends in 
urine and hand-wipe concentrations of 2,4-D 
(Coble et al. 2005; Thomas et al. 2009) and 
urine concentrations of MCPA (Coble et al. 
2005), and in general, biomarker levels tended 
to be greatest among participants labeled as 
having the highest exposures (Acquavella et al. 
2006; Thomas et al. 2009).
Exposure misclassification undoubtedly 
had an impact on AHS findings reported 
to date. As participants reported exposures 
prior to disease onset, the process of exposure 
misclassification in the AHS cohort is likely 
to be nondifferential; however, this does not 
guarantee bias toward the null in any indi-
vidual study (Dosemeci et al. 1990; Jurek 
et al. 2005; 2008; Pearce et al. 2007; Sorahan 
and Gilthorpe 1994; Thomas 1995). What 
seems apparent from validation studies is that 
the exposure intensity algorithm is capable of 
differentiating subjects with the highest and 
lowest exposure levels but is less capable of 
valid exposure classification across an exposure 
gradient. Unfortunately, this limits the ability 
to detect exposure–response patterns, as sub-
stantial exposure misclassification is expected 
to occur across categories of exposure. Further 
validation of the exposure intensity algorithm 
in biomonitoring studies for an expanded 
group of pesticides may help to characterize Weichenthal et al.
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this uncertainty. Similarly, the applicability of 
intensity-weighted exposure measures in stud-
ies of lung cancer requires further evaluation, 
as the algorithm weighs dermal exposures 
most heavily (Dosemeci et al. 2002) and may 
not offer an improvement over lifetime-expo-
sure days for outcomes related to inhalation 
exposures. Finally, it is not clear how current 
exposure levels compare with those during 
etiologically relevant time periods, as the first 
years of pesticide use often occurred decades 
prior to enrollment in the AHS.
Conclusions
We reviewed 28 studies of pesticide expo-
sure and cancer incidence in the AHS cohort. 
Most of the 32 pesticides examined were not 
strongly associated with cancer, but increased 
RRs/ORs and positive exposure–response 
relationships were observed for 12 pesti-
cides currently registered in Canada and/or 
the United States. However, RRs and ORs 
were often imprecise because of small num-
bers of exposed cases, and further follow-up 
is required once more cases have accrued. 
Epidemiologic evidence outside the AHS 
cohort remains limited with respect to most 
of the observed associations, but animal toxic-
ity data support the possible carcinogenicity 
of alachlor, carbaryl, metolachlor, pendime-
thalin, permethrin, and trifluralin. Although 
the exposure intensity algorithm developed 
for the AHS offers an improvement over ever/
never exposure classification often employed 
in environmental health studies, exposure 
misclassification remains a concern. In par-
ticular, analysis of exposure–response trends 
is limited by expected exposure misclassifica-
tion across categories of LDs and IWLDs. 
Further validation of the exposure intensity 
algorithm for an expanded group of pesticides 
will help to characterize uncertainty resulting 
from exposure misclassification. In addition, 
continued follow-up of the AHS cohort as a 
whole will help to clarify associations reported 
to date. In doing so, particular attention 
should be paid to registered pesticides that 
displayed evidence of a possible association 
with cancer.
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